MeDIP-Seq/DIP-Seq/hMeDIP-Seq

MeDIP-Seq/DIP-Seq/hMeDIP-Seq

Methylated DNA immunoprecipitation sequencing (MeDIP-Seq), DNA immunoprecipitation sequencing (DIP-Seq) or Hydroxymethylated DNA immunoprecipitation sequencing (hMeDIP-Seq), is commonly used to study 5mC or 5hmC modification. Specific antibodies can be used to study cytosine modifications. If using 5mC-specific antibodies, methylated DNA is isolated from genomic DNA via immunoprecipitation. Anti-5mC antibodies are incubated with fragmented genomic DNA and precipitated, followed by DNA purification and sequencing. Deep sequencing provides greater genome coverage, representing the majority of immunoprecipitated methylated DNA.

  • MeDIP-Seq: Weber M., Davies J. J., Wittig D., Oakeley E. J., Haase M., et al. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37: 853-862
  • DIP-Seq: Shen L., Wu H., Diep D., Yamaguchi S., D'Alessio A. C., et al. (2013) Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 153: 692-706
  • hMeDIP-Seq: Jin C., Lu Y., Jelinek J., Liang S., Estecio M. R., et al. (2014) TET1 is a maintenance DNA demethylase that prevents methylation spreading in differentiated cells. Nucleic Acids Res 42: 6956-6971